chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Headache, Malaise, Nausea
Clinical narrative: Energy level low; Achy feeling; sick feeling; Chills; headache; nausea comes and goes; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Energy level low), PAIN (Achy feeling), MALAISE (sick feeling), CHILLS (Chills) and HEADACHE (headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced ASTHENIA (Energy level low), MALAISE (sick feeling), CHILLS (Chills), HEADACHE (headache) and NAUSEA (nausea comes and goes). 12-Mar-2021, the patient experienced PAIN (Achy feeling). At the time of the report, ASTHENIA (Energy level low), PAIN (Achy feeling), MALAISE (sick feeling), CHILLS (Chills), HEADACHE (headache) and NAUSEA (nausea comes and goes) outcome was unknown.            Concomitant medications were not provided.  Treatment information was not provided. The action taken with  mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) was not applicable.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Energy level low; Achy feeling; sick feeling; Chills; headache; nausea comes and goes; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Energy level low), PAIN (Achy feeling), MALAISE (sick feeling), CHILLS (Chills) and HEADACHE (headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced ASTHENIA (Energy level low), MALAISE (sick feeling), CHILLS (Chills), HEADACHE (headache) and NAUSEA (nausea comes and goes). 12-Mar-2021, the patient experienced PAIN (Achy feeling). At the time of the report, ASTHENIA (Energy level low), PAIN (Achy feeling), MALAISE (sick feeling), CHILLS (Chills), HEADACHE (headache) and NAUSEA (nausea comes and goes) outcome was unknown.            Concomitant medications were not provided.  Treatment information was not provided. The action taken with  mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) was not applicable.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Interchange of vaccine products, Product dose omission issue
Clinical narrative: took the Pfizer vaccine; Second Shot April 3; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Second Shot April 3) and INTERCHANGE OF VACCINE PRODUCTS (took the Pfizer vaccine) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Second Shot April 3). On 03-Apr-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (took the Pfizer vaccine). On 17-Feb-2021, PRODUCT DOSE OMISSION ISSUE (Second Shot April 3) had resolved. On 03-Apr-2021, INTERCHANGE OF VACCINE PRODUCTS (took the Pfizer vaccine) had resolved. Not Provided          Patient administered first dose of Moderna vaccine and later administered second dose of Pfizer vaccine.  No concomitant medication information was reported.  No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: 2nd dose information updated. This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 30-Mar-2021. The most recent information was received on 01-Jul-2021 and was forwarded to Moderna on 01-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Second Shot April 3) and INTERCHANGE OF VACCINE PRODUCTS (took the Pfizer vaccine) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Second Shot April 3). On 03-Apr-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (took the Pfizer vaccine). On 17-Feb-2021, PRODUCT DOSE OMISSION ISSUE (Second Shot April 3) had resolved. On 03-Apr-2021, INTERCHANGE OF VACCINE PRODUCTS (took the Pfizer vaccine) had resolved. Not Provided          Patient administered first dose of Moderna vaccine and later administered second dose of Pfizer vaccine.  No concomitant medication information was reported.  No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: 2nd dose information updated.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Fatigue, Pain in extremity, Pyrexia, Rash erythematous
Clinical narrative: Arm pain; Red rash around the injection site; Fever; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain), RASH ERYTHEMATOUS (Red rash around the injection site), FATIGUE (Fatigue) and PYREXIA (Fever) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   On 25-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced FATIGUE (Fatigue). On 29-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm pain), RASH ERYTHEMATOUS (Red rash around the injection site) and PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (Arm pain), RASH ERYTHEMATOUS (Red rash around the injection site), FATIGUE (Fatigue) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Mar-2021, Blood pressure measurement: increased (High) increased.         Concomitant Product information was not provided. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 68.0
Sex: U
Vaccine: COVID19
Symptoms: Chills, Headache, Rhinorrhoea
Clinical narrative: non stop runny nose; worst headache of my life; Chills; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (non stop runny nose), HEADACHE (worst headache of my life) and CHILLS (Chills) in a 68-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RHINORRHOEA (non stop runny nose), HEADACHE (worst headache of my life) and CHILLS (Chills). At the time of the report, RHINORRHOEA (non stop runny nose), HEADACHE (worst headache of my life) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not reported. Treatment medication was not reported. Upon internal review on 04-Aug-2021, the age was corrected to 68 years.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose, Blood glucose increased
Clinical narrative: 2 male patients had a spike in their glucose blood numbers about 80 points -went to 120 over 200; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (2 male patients had a spike in their glucose blood numbers about 80 points -went to 120 over 200) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Fibroids, Diabetes, Blood pressure high, Stenosis (patient took several prescribed medicines to treat those conditions.) and Drug allergy.    On 07-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jan-2021, the patient experienced BLOOD GLUCOSE INCREASED (2 male patients had a spike in their glucose blood numbers about 80 points -went to 120 over 200). On 10-Jan-2021, BLOOD GLUCOSE INCREASED (2 male patients had a spike in their glucose blood numbers about 80 points -went to 120 over 200) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, Blood glucose: 80 points (High) and went to120 to over 200.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were not reported.   Patient took Metformin twice a day to treat this symptoms.     This case was linked to MOD-2021-063233, MOD-2021-009572 (Patient Link).
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Headache, Hypersomnia, Hypertension
Clinical narrative: Sleeping a lot; Slight headache; Extremely high blood pressure; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (Extremely high blood pressure), HYPERSOMNIA (Sleeping a lot) and HEADACHE (Slight headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B212A and 045B21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes since 01-Jan-2014, Hypothyroidism since 01-Jan-1993, Latex allergy and Allergy to chemicals (Ethylenediamine). Concomitant products included ESOMEPRAZOLE MAGNESIUM (ESOMEPRAZOLE ACCORD [ESOMEPRAZOLE MAGNESIUM]) for Acid reflux (oesophageal), INSULIN DEGLUDEC (TRESIBA FLEXTOUCH) and INSULIN HUMAN (HUMULIN R) for Diabetes, VARENICLINE TARTRATE (CHANTIX) for Smoking cessation therapy.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced HYPERTENSION (Extremely high blood pressure) and HEADACHE (Slight headache). On an unknown date, the patient experienced HYPERSOMNIA (Sleeping a lot). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 01-Apr-2021, HEADACHE (Slight headache) had resolved. At the time of the report, HYPERTENSION (Extremely high blood pressure) and HYPERSOMNIA (Sleeping a lot) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Mar-2021, Blood pressure measurement: 135/85 mmHg (High) 135/85. On 28-Mar-2021, Blood pressure measurement: 143/86 mmHg (High) 143/86. On 30-Mar-2021, Blood pressure measurement: 141/87 mmHg (High) The blood pressure came down to 127/83 mmHg.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient took hot bath.   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Follow up was added on 13 May 2021 included other relevant history, concomitant medications, second dose details was added and event outcome of the headache and action taken was updated.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Headache, Nausea
Clinical narrative: Daughter felt weak; Nausea; Severe headache that causing her to cry; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Daughter felt weak), NAUSEA (Nausea) and HEADACHE (Severe headache that causing her to cry) in a 121-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022m20a) for COVID-19 immunization.     No Medical History information was reported.    On 23-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced ASTHENIA (Daughter felt weak), NAUSEA (Nausea) and HEADACHE (Severe headache that causing her to cry). At the time of the report, ASTHENIA (Daughter felt weak), NAUSEA (Nausea) and HEADACHE (Severe headache that causing her to cry) outcome was unknown.            Concomitant medications included anxiety medicines.   This case was linked to MOD-2021-057685 (Patient Link).
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Received the 1st dose of the Moderna vaccine 48 days ago; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Received the 1st dose of the Moderna vaccine 48 days ago) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Received the 1st dose of the Moderna vaccine 48 days ago). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Received the 1st dose of the Moderna vaccine 48 days ago) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   No corrective treatment was provided.   Reporter did not allow further contact
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Insomnia, Lymphadenopathy, Malaise
Clinical narrative: Nightmares; Rash in the upper left arm, then back and left ear, described it as veryitchy; inflammation of her left arm and and its lymph nodes; Tiredness; General malaise; Lack of sleep; Weakness; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Lack of sleep), ASTHENIA (Weakness), NIGHTMARE (Nightmares), MALAISE (General malaise) and RASH PRURITIC (Rash in the upper left arm, then back and left ear, described it as veryitchy) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A or 051A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced INSOMNIA (Lack of sleep), ASTHENIA (Weakness), MALAISE (General malaise), LYMPHADENOPATHY (inflammation of her left arm and and its lymph nodes) and FATIGUE (Tiredness). On 27-Mar-2021, the patient experienced RASH PRURITIC (Rash in the upper left arm, then back and left ear, described it as veryitchy). On an unknown date, the patient experienced NIGHTMARE (Nightmares). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itchy rash, at an unspecified dose and frequency. On 30-Mar-2021, RASH PRURITIC (Rash in the upper left arm, then back and left ear, described it as veryitchy) had resolved. At the time of the report, INSOMNIA (Lack of sleep), ASTHENIA (Weakness), NIGHTMARE (Nightmares), MALAISE (General malaise), LYMPHADENOPATHY (inflammation of her left arm and and its lymph nodes) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Non significant follow up received on 13 MAY 2021, Reporter information updated
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Nightmare, Rash pruritic
Clinical narrative: Nightmares; Rash in the upper left arm, then back and left ear, described it as veryitchy; inflammation of her left arm and and its lymph nodes; Tiredness; General malaise; Lack of sleep; Weakness; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Lack of sleep), ASTHENIA (Weakness), NIGHTMARE (Nightmares), MALAISE (General malaise) and RASH PRURITIC (Rash in the upper left arm, then back and left ear, described it as veryitchy) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A or 051A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced INSOMNIA (Lack of sleep), ASTHENIA (Weakness), MALAISE (General malaise), LYMPHADENOPATHY (inflammation of her left arm and and its lymph nodes) and FATIGUE (Tiredness). On 27-Mar-2021, the patient experienced RASH PRURITIC (Rash in the upper left arm, then back and left ear, described it as veryitchy). On an unknown date, the patient experienced NIGHTMARE (Nightmares). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itchy rash, at an unspecified dose and frequency. On 30-Mar-2021, RASH PRURITIC (Rash in the upper left arm, then back and left ear, described it as veryitchy) had resolved. At the time of the report, INSOMNIA (Lack of sleep), ASTHENIA (Weakness), NIGHTMARE (Nightmares), MALAISE (General malaise), LYMPHADENOPATHY (inflammation of her left arm and and its lymph nodes) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Non significant follow up received on 13 MAY 2021, Reporter information updated
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Blood glucose increased
Clinical narrative: 3 female patients had a spike in blood sugar number after receiving the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (3 female patients had a spike in blood sugar number after receiving the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes, Blood pressure high, Fibroids, Stenosis and Drug allergy (Loratad allergy).    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jan-2021, the patient experienced BLOOD GLUCOSE INCREASED (3 female patients had a spike in blood sugar number after receiving the vaccine). On 10-Jan-2021, BLOOD GLUCOSE INCREASED (3 female patients had a spike in blood sugar number after receiving the vaccine) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, Blood glucose: 200 blood sugar spike about 80 points- went 120 to over 200.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment of the event included, metformin twice daily.  No concomitant medications were reported.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Injection site itches; Nausea; Muscle pain; Rash at the injection site; injection site stings; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Injection site itches), NAUSEA (Nausea), MYALGIA (Muscle pain), VACCINATION SITE RASH (Rash at the injection site) and VACCINATION SITE PAIN (injection site stings) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Injection site itches), NAUSEA (Nausea), MYALGIA (Muscle pain) and VACCINATION SITE RASH (Rash at the injection site). 29-Mar-2021, the patient experienced VACCINATION SITE PAIN (injection site stings). At the time of the report, VACCINATION SITE PRURITUS (Injection site itches), NAUSEA (Nausea), MYALGIA (Muscle pain), VACCINATION SITE RASH (Rash at the injection site) and VACCINATION SITE PAIN (injection site stings) outcome was unknown.            No concomitant medications were reported. No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: Reporter Email id is added
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: itchy injection site; swollen injection site; injection site redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchy injection site), VACCINATION SITE SWELLING (swollen injection site) and INJECTION SITE ERYTHEMA (injection site redness) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     No medical history information was reported.  Concomitant products included PANTOPRAZOLE and SUCRALFATE for an unknown indication.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced VACCINATION SITE SWELLING (swollen injection site) and INJECTION SITE ERYTHEMA (injection site redness). On 21-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itchy injection site). At the time of the report, VACCINATION SITE PRURITUS (itchy injection site), VACCINATION SITE SWELLING (swollen injection site) and INJECTION SITE ERYTHEMA (injection site redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  Patient was reported to use ice pack for the reported events.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Limb discomfort, Mobility decreased, Vaccination site pain
Clinical narrative: had a really hard time lifting his right arm; could not raise the arm about his shoulder; t's still extremely painful; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (had a really hard time lifting his right arm), MOBILITY DECREASED (could not raise the arm about his shoulder) and VACCINATION SITE PAIN (t's still extremely painful) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information was provided.  Concomitant products included OMEPRAZOLE for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced LIMB DISCOMFORT (had a really hard time lifting his right arm), MOBILITY DECREASED (could not raise the arm about his shoulder) and VACCINATION SITE PAIN (t's still extremely painful). The patient was treated with NAPROXEN SODIUM (ALEVE) for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, LIMB DISCOMFORT (had a really hard time lifting his right arm) had not resolved, MOBILITY DECREASED (could not raise the arm about his shoulder) was resolving and VACCINATION SITE PAIN (t's still extremely painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Chills, Dyskinesia, Fatigue
Clinical narrative: fatigue; awaking "soaking wet"; shoulder pain; headache; knee pain (bilateral); chills; back pain; inability to move left arm; sweating; cold sensation; left arm hurting; achy; inability to sleep; whole body hurting; feeling "hit by a truck"; feeling "like you have the flu"; sleeping; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (left arm hurting), PAIN (achy), INSOMNIA (inability to sleep), PAIN (whole body hurting) and FEELING ABNORMAL (feeling "hit by a truck") in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included SARS-CoV-2 test on 25-Dec-2020 and Back surgery (5 Back surgeries). Concurrent medical conditions included Psoriasis. Concomitant products included GABAPENTIN, NAPROXEN, PARACETAMOL (TYLENOL), TURMERIC [CURCUMA LONGA RHIZOME] and DULOXETINE HYDROCHLORIDE (CYMBALTA) for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced PAIN IN EXTREMITY (left arm hurting), PAIN (achy), INSOMNIA (inability to sleep), PAIN (whole body hurting), FEELING ABNORMAL (feeling "hit by a truck"), INFLUENZA (feeling "like you have the flu") and SOMNOLENCE (sleeping). On 26-Mar-2021, the patient experienced BACK PAIN (back pain), DYSKINESIA (inability to move left arm), HYPERHIDROSIS (sweating), FEELING COLD (cold sensation), ARTHRALGIA (shoulder pain), HEADACHE (headache), ARTHRALGIA (knee pain (bilateral)) and CHILLS (chills). On 27-Mar-2021, the patient experienced HYPERHIDROSIS (awaking "soaking wet"). On 30-Mar-2021, the patient experienced FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. On 30-Mar-2021, PAIN IN EXTREMITY (left arm hurting), PAIN (achy), INSOMNIA (inability to sleep), PAIN (whole body hurting), FEELING ABNORMAL (feeling "hit by a truck"), INFLUENZA (feeling "like you have the flu"), SOMNOLENCE (sleeping), BACK PAIN (back pain), DYSKINESIA (inability to move left arm), FEELING COLD (cold sensation), HYPERHIDROSIS (awaking "soaking wet") and ARTHRALGIA (shoulder pain) had resolved. At the time of the report, HYPERHIDROSIS (sweating), FATIGUE (fatigue), HEADACHE (headache), ARTHRALGIA (knee pain (bilateral)) and CHILLS (chills) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Psoriatic arthropathy: negative (Negative) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Feeling cold, Headache, Hyperhidrosis, Influenza
Clinical narrative: fatigue; awaking "soaking wet"; shoulder pain; headache; knee pain (bilateral); chills; back pain; inability to move left arm; sweating; cold sensation; left arm hurting; achy; inability to sleep; whole body hurting; feeling "hit by a truck"; feeling "like you have the flu"; sleeping; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (left arm hurting), PAIN (achy), INSOMNIA (inability to sleep), PAIN (whole body hurting) and FEELING ABNORMAL (feeling "hit by a truck") in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included SARS-CoV-2 test on 25-Dec-2020 and Back surgery (5 Back surgeries). Concurrent medical conditions included Psoriasis. Concomitant products included GABAPENTIN, NAPROXEN, PARACETAMOL (TYLENOL), TURMERIC [CURCUMA LONGA RHIZOME] and DULOXETINE HYDROCHLORIDE (CYMBALTA) for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced PAIN IN EXTREMITY (left arm hurting), PAIN (achy), INSOMNIA (inability to sleep), PAIN (whole body hurting), FEELING ABNORMAL (feeling "hit by a truck"), INFLUENZA (feeling "like you have the flu") and SOMNOLENCE (sleeping). On 26-Mar-2021, the patient experienced BACK PAIN (back pain), DYSKINESIA (inability to move left arm), HYPERHIDROSIS (sweating), FEELING COLD (cold sensation), ARTHRALGIA (shoulder pain), HEADACHE (headache), ARTHRALGIA (knee pain (bilateral)) and CHILLS (chills). On 27-Mar-2021, the patient experienced HYPERHIDROSIS (awaking "soaking wet"). On 30-Mar-2021, the patient experienced FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. On 30-Mar-2021, PAIN IN EXTREMITY (left arm hurting), PAIN (achy), INSOMNIA (inability to sleep), PAIN (whole body hurting), FEELING ABNORMAL (feeling "hit by a truck"), INFLUENZA (feeling "like you have the flu"), SOMNOLENCE (sleeping), BACK PAIN (back pain), DYSKINESIA (inability to move left arm), FEELING COLD (cold sensation), HYPERHIDROSIS (awaking "soaking wet") and ARTHRALGIA (shoulder pain) had resolved. At the time of the report, HYPERHIDROSIS (sweating), FATIGUE (fatigue), HEADACHE (headache), ARTHRALGIA (knee pain (bilateral)) and CHILLS (chills) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Psoriatic arthropathy: negative (Negative) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Pain, Pain in extremity, Psoriatic arthropathy, Somnolence
Clinical narrative: fatigue; awaking "soaking wet"; shoulder pain; headache; knee pain (bilateral); chills; back pain; inability to move left arm; sweating; cold sensation; left arm hurting; achy; inability to sleep; whole body hurting; feeling "hit by a truck"; feeling "like you have the flu"; sleeping; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (left arm hurting), PAIN (achy), INSOMNIA (inability to sleep), PAIN (whole body hurting) and FEELING ABNORMAL (feeling "hit by a truck") in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included SARS-CoV-2 test on 25-Dec-2020 and Back surgery (5 Back surgeries). Concurrent medical conditions included Psoriasis. Concomitant products included GABAPENTIN, NAPROXEN, PARACETAMOL (TYLENOL), TURMERIC [CURCUMA LONGA RHIZOME] and DULOXETINE HYDROCHLORIDE (CYMBALTA) for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced PAIN IN EXTREMITY (left arm hurting), PAIN (achy), INSOMNIA (inability to sleep), PAIN (whole body hurting), FEELING ABNORMAL (feeling "hit by a truck"), INFLUENZA (feeling "like you have the flu") and SOMNOLENCE (sleeping). On 26-Mar-2021, the patient experienced BACK PAIN (back pain), DYSKINESIA (inability to move left arm), HYPERHIDROSIS (sweating), FEELING COLD (cold sensation), ARTHRALGIA (shoulder pain), HEADACHE (headache), ARTHRALGIA (knee pain (bilateral)) and CHILLS (chills). On 27-Mar-2021, the patient experienced HYPERHIDROSIS (awaking "soaking wet"). On 30-Mar-2021, the patient experienced FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. On 30-Mar-2021, PAIN IN EXTREMITY (left arm hurting), PAIN (achy), INSOMNIA (inability to sleep), PAIN (whole body hurting), FEELING ABNORMAL (feeling "hit by a truck"), INFLUENZA (feeling "like you have the flu"), SOMNOLENCE (sleeping), BACK PAIN (back pain), DYSKINESIA (inability to move left arm), FEELING COLD (cold sensation), HYPERHIDROSIS (awaking "soaking wet") and ARTHRALGIA (shoulder pain) had resolved. At the time of the report, HYPERHIDROSIS (sweating), FATIGUE (fatigue), HEADACHE (headache), ARTHRALGIA (knee pain (bilateral)) and CHILLS (chills) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Psoriatic arthropathy: negative (Negative) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Dizziness, Fatigue
Clinical narrative: Dizziness; Extreme dizziness; Dizziness; Feels washed out; Weakness; Fatigue; Chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of the first episode of DIZZINESS (Dizziness), DIZZINESS (Extreme dizziness), the second episode of DIZZINESS (Dizziness), ASTHENIA (Weakness) and FATIGUE (Fatigue) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 047A211A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Stent placement (5 stents). Concurrent medical conditions included Diabetes, Blood pressure high, Drug allergy (Bactroban ointment) and Heart disorder. Concomitant products included LEVOTHYROXINE, LOSARTAN, SITAGLIPTIN PHOSPHATE (JANUVIA), CLOPIDOGREL, IRON (FERROUS [IRON]), FAMOTIDINE, PRAVASTATIN, AMLODIPINE and LATANOPROST for an unknown indication.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular).5 ml. On 25-Mar-2021, the patient experienced FATIGUE (Fatigue) and CHILLS (Chills). On 29-Mar-2021, the patient experienced the first episode of DIZZINESS (Dizziness), ASTHENIA (Weakness) and FATIGUE (Feels washed out). On 05-Apr-2021, the patient experienced DIZZINESS (Extreme dizziness). On 12-Apr-2021, the patient experienced the second episode of DIZZINESS (Dizziness). The patient was treated with MECLIZINE [MECLOZINE] for Dizziness, at a dose of 12.5 mg three times a day. At the time of the report, DIZZINESS (Extreme dizziness) and the last episode of DIZZINESS (Dizziness) had resolved and ASTHENIA (Weakness), FATIGUE (Fatigue), CHILLS (Chills) and FATIGUE (Feels washed out) outcome was unknown.            Patient reported that a brain scan was performed on an unspecified date to determine if she experienced a stroke. Results were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Added patient medical history,adverse event recurrence, concomitant medications, and treatment reported.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Rash
Clinical narrative: rash on neck, stomach; mild weakness; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on neck, stomach) and ASTHENIA (mild weakness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (rash on neck, stomach) and ASTHENIA (mild weakness). At the time of the report, RASH (rash on neck, stomach) and ASTHENIA (mild weakness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information not provided. Treatment information not provided
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia, Tremor
Clinical narrative: Shaking of extremities; Fever 100.8F; Chills; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Shaking of extremities), PYREXIA (Fever 100.8F) and CHILLS (Chills) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced TREMOR (Shaking of extremities), PYREXIA (Fever 100.8F) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, TREMOR (Shaking of extremities), PYREXIA (Fever 100.8F) and CHILLS (Chills) outcome was unknown.            No concomitant medications were provided. Action taken with mRNA-1273 in response to the events was not applicable.    This case was linked to MOD-2021-067030 (Patient Link).
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Product dose omission issue
Clinical narrative: Has not received the 2nd vaccine; Covid-19 positive; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19 positive) and PRODUCT DOSE OMISSION ISSUE (Has not received the 2nd vaccine) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced COVID-19 (Covid-19 positive). On 30-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Has not received the 2nd vaccine). On 30-Mar-2021, PRODUCT DOSE OMISSION ISSUE (Has not received the 2nd vaccine) had resolved. At the time of the report, COVID-19 (Covid-19 positive) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication information not provided. Treatment information not provided.    This case was linked to MOD21-12105 (E2B Linked Report).; Sender's Comments:  MOD21-12105:
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash all over body; started at neck/shoulder and worked it's way down to ankles; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash all over body; started at neck/shoulder and worked it's way down to ankles) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (rash all over body; started at neck/shoulder and worked it's way down to ankles). At the time of the report, RASH (rash all over body; started at neck/shoulder and worked it's way down to ankles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  No treatment medications were provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication list was not provided. Treatment information was not provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Itchiness; Redness, rash and swollen arm of injection; Rash; Hot rash; Swollen on the arm of injection; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 30-Mar-2021 and was forwarded to Moderna on 30-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness), VACCINATION SITE ERYTHEMA (Redness, rash and swollen arm of injection), RASH (Rash), VACCINATION SITE WARMTH (Hot rash) and VACCINATION SITE SWELLING (Swollen on the arm of injection) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction. Concomitant products included CAPTOPRIL, VITAMIN D3 and CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]) for an unknown indication.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced PRURITUS (Itchiness), VACCINATION SITE ERYTHEMA (Redness, rash and swollen arm of injection), RASH (Rash), VACCINATION SITE WARMTH (Hot rash) and VACCINATION SITE SWELLING (Swollen on the arm of injection). At the time of the report, PRURITUS (Itchiness), VACCINATION SITE ERYTHEMA (Redness, rash and swollen arm of injection), RASH (Rash), VACCINATION SITE WARMTH (Hot rash) and VACCINATION SITE SWELLING (Swollen on the arm of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Other Concomitant Medication: Centrum silver.  Treatment provided was Aller-Tec started when itchiness started.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain at the Injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at the Injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced VACCINATION SITE PAIN (Pain at the Injection site). At the time of the report, VACCINATION SITE PAIN (Pain at the Injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was reported.
Sex: U
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: Allergic reaction; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of HYPERSENSITIVITY (Allergic reaction) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (Allergic reaction). At the time of the report, HYPERSENSITIVITY (Allergic reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was reported.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Heart rate increased, Hyperhidrosis, Hypersensitivity, Tremor
Clinical narrative: Fast Heart Beat; Hot Sweats/Cold Sweats; Hands were shaking; allergic reaction; Did not feel like she could drive for 45 minutes post vaccine; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Fast Heart Beat), HYPERHIDROSIS (Hot Sweats/Cold Sweats), TREMOR (Hands were shaking), HYPERSENSITIVITY (allergic reaction) and FEELING ABNORMAL (Did not feel like she could drive for 45 minutes post vaccine) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced HEART RATE INCREASED (Fast Heart Beat), HYPERHIDROSIS (Hot Sweats/Cold Sweats), TREMOR (Hands were shaking), HYPERSENSITIVITY (allergic reaction) and FEELING ABNORMAL (Did not feel like she could drive for 45 minutes post vaccine). On 27-Mar-2021, HEART RATE INCREASED (Fast Heart Beat), HYPERHIDROSIS (Hot Sweats/Cold Sweats), TREMOR (Hands were shaking), HYPERSENSITIVITY (allergic reaction) and FEELING ABNORMAL (Did not feel like she could drive for 45 minutes post vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.